tdholodok.ru
Log In

Frontiers Cancer, more than a “COVID-19 co-morbidity”

$ 11.50

4.7 (369) In stock

PDF) Impact of COVID-19 on cancer care pathways in a comprehensive

Frontiers Biological effects of COVID-19 on lung cancer: Can we

Pathogens, Free Full-Text

FAST: a fast and scalable factor analysis for spatially aware

Frontiers The Sum of Fears in Cancer Patients Inside the Context

Which Comorbidities Increase the Risk of a COVID-19 Breakthrough

PDF) Cancer, more than a “COVID-19 co-morbidity”

Frontiers Case report: Understanding the impact of persistent

PDF) Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in

Frontiers The risk profile of patients with COVID-19 as

Frontiers Cancer, more than a “COVID-19 co-morbidity”

Related products

The myeloproliferative blood cancers—essential thrombocytosis (ET)

Essential thrombocythaemia (ET) symptoms and tests

The holy grail: pan-cancer-targeting T cells

Résistance hormonale, méthylation et cancer du sein - CRCL

Alcool et cancer du sein - Facteur de risque accru, qu'en est il?